WallStreetZenWallStreetZen

NASDAQ: ORKA
Oruka Therapeutics Inc Stock Ownership - Who owns Oruka Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Oruka Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Fairmount Funds Management LLCDirector2025-09-17333,340$15.00
$5.00MBuy
Venrock Healthcare Capital Partners III LP10% Owner2025-02-1488,794$11.44
$1.02MBuy
Venrock Healthcare Capital Partners III LP10% Owner2025-02-1314,950$11.63
$173.87kBuy
Venrock Healthcare Capital Partners III LP10% Owner2025-02-128,971$11.86
$106.40kBuy
Venrock Healthcare Capital Partners III LP10% Owner2025-02-119,593$10.95
$105.04kBuy
Venrock Healthcare Capital Partners III LP10% Owner2025-02-10574$10.90
$6.26kBuy

1 of 1

ORKA insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ORKA insiders and whales buy or sell their stock.

ORKA Shareholders

What type of owners hold Oruka Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ravi Viswanathan27.29%10,221,465$271.48MInsider
Krishna Kittu Kolluri27.29%10,221,465$271.48MInsider
Anthony A. Florence Jr.27.29%10,221,465$271.48MInsider
Peter W. Sonsini27.29%10,221,465$271.48MInsider
Forest Baskett27.29%10,221,465$271.48MInsider
Peter J. Barris27.29%10,221,465$271.48MInsider
Harry R. Weller27.29%10,221,465$271.48MInsider
David M. Mott27.29%10,221,465$271.48MInsider
Scott D. Sandell27.29%10,221,465$271.48MInsider
Jon Sakoda27.29%10,221,465$271.48MInsider

1 of 3

ORKA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ORKA18.31%81.69%Net BuyingNet Buying
MNMD48.27%51.73%Net SellingNet Selling
ZBIO64.89%35.11%Net BuyingNet Buying
XNCR72.16%27.84%Net Selling
TNGX60.44%39.56%Net SellingNet Selling
View Top Biotech Stocks

Oruka Therapeutics Stock Ownership FAQ

Who owns Oruka Therapeutics?

Oruka Therapeutics (NASDAQ: ORKA) is owned by 91.93% institutional shareholders, 410.15% Oruka Therapeutics insiders, and 0.00% retail investors. Ravi Viswanathan is the largest individual Oruka Therapeutics shareholder, owning 10.22M shares representing 27.29% of the company. Ravi Viswanathan's Oruka Therapeutics shares are currently valued at $280.89M.

If you're new to stock investing, here's how to buy Oruka Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.